Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage
Myriad Genetics (NASDAQ:MYGN) is down ~20% in Friday trading following reports that UnitedHealth Group (UNH) will no longer ...
Myriad Genetics in Active Talks with UnitedHealthcare to Keep Coverage of GeneSight
Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.
UnitedHealth update ‘not the end’ for Myriad’s GeneSight, says Raymond James
UnitedHealth (UNH) on Friday disclosed that it would stop covering multi-panel pharmacogenetic tests, including Myriad’s (MYGN) ...
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...
Nasdaq4d
Piper says Myriad appears to be trading down on GeneSight coverage change
Piper Sandler thinks Myriad Genetics (MYGN), which has seen its shares fall nearly 22% on Friday morning, is trading down on a coverage decision on GeneSight by UnitedHealth (UNH), which will take ...
How are Americans feeling before Election Day?
Election season is in full swing, but as anyone can tell you, campaigns begin to enter their full speed much earlier in the ...
Myriad weakness due to UnitedHealth coverage update, says Stephens
Stephens analyst Mason Carrico notes that Myriad Genetics (MYGN) shares are down about 20% this morning, which the firm ...
EurekAlert!1y
The GeneSight Test (IMAGE)
With a simple cheek swab, the GeneSight test generates a report that gives healthcare providers insight into how a patient may metabolize or respond to certain psychiatric medications.
Psychology Today2y
Blue Water Psychiatry
Your brain health is our business. We offer GeneSight® Psychotropic testing for those who may not be responding to multiple medication trials. We offer treatment for depression, anxiety ...
Psychology Today5mon
Lesley Rothschild
Please note that I do not sub-specialize in geriatrics. Pharmacogenetic DNA testing via Genomind and GeneSight is available for appropriate patients. In my practice, I use an individualized ...
Seeking Alpha4d
Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage
Notes from several investment houses indicate that the insurance giant will no longer cover genetic tests for behavioral health, which includes Myriad's GeneSight, beginning Jan. 1, 2025.
Nasdaq4d
UnitedHealth update ‘not the end’ for Myriad’s GeneSight, says Raymond James
UnitedHealth (UNH) on Friday disclosed that it would stop covering multi-panel pharmacogenetic tests, including Myriad’s (MYGN) GeneSight, effective January 1, 2025, in a number of plans ...